140 related articles for article (PubMed ID: 28352186)
1. Tyrosine kinase domain mutations of
Vatte C; Al Amri AM; Cyrus C; Chathoth S; Acharya S; Hashim TM; Al Ali Z; Alshreadah ST; Alsayyah A; Al-Ali AK
Onco Targets Ther; 2017; 10():1527-1533. PubMed ID: 28352186
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor (EGFR) mutations as biomarker for head and neck squamous cell carcinomas (HNSCC).
Nagalakshmi K; Jamil K; Pingali U; Reddy MV; Attili SS
Biomarkers; 2014 May; 19(3):198-206. PubMed ID: 24712396
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
Uribe P; Gonzalez S
Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
[TBL] [Abstract][Full Text] [Related]
4. [Detection of epidermal growth factor receptor gene mutations in non-small cell lung cancers by real-time polymerase chain reaction using scorpion amplification refractory mutation system].
Zhang J; Liang ZY; Zeng X; Wu SF; Gao J; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):294-9. PubMed ID: 18956645
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of EGFR Tyrosine Kinase Domain Mutations in Head and Neck Squamous Cell Carcinoma: Cohort Study and Systematic Review.
Perisanidis C
In Vivo; 2017 Jan; 31(1):23-34. PubMed ID: 28064216
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas.
Szabó B; Nelhubel GA; Kárpáti A; Kenessey I; Jóri B; Székely C; Peták I; Lotz G; Hegedus Z; Hegedus B; Füle T; Döme B; Tímár J; Tóvári J
Oral Oncol; 2011 Jun; 47(6):487-96. PubMed ID: 21498106
[TBL] [Abstract][Full Text] [Related]
7. Screening for EGFR mutations in lung cancer, a report from India.
Sahoo R; Harini VV; Babu VC; Patil Okaly GV; Rao S; Nargund A; Venkataswamy E; Rao R; Kumar BS
Lung Cancer; 2011 Sep; 73(3):316-9. PubMed ID: 21315473
[TBL] [Abstract][Full Text] [Related]
8. Study of EGFR mutations in head and neck squamous cell carcinomas.
Kaur G; Phogat D; Manu V
Autops Case Rep; 2021 Apr; 11():e2021251. PubMed ID: 33968826
[TBL] [Abstract][Full Text] [Related]
9. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
[TBL] [Abstract][Full Text] [Related]
10. Identification of the rare EGFR mutation p.G796S as somatic and germline mutation in white patients with squamous cell carcinoma of the head and neck.
Schwentner I; Witsch-Baumgartner M; Sprinzl GM; Krugmann J; Tzankov A; Jank S; Zwierzina H; Loeffler-Ragg J
Head Neck; 2008 Aug; 30(8):1040-4. PubMed ID: 18528899
[TBL] [Abstract][Full Text] [Related]
11. [Detection of epidermal growth factor receptor mutations in non-small cell lung cancer by real-time PCR using TaqMan-MGB probes].
Zhou CC; Zhou SW; Pan H; Su B; Gao ZQ
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):119-23. PubMed ID: 17645848
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor (EGFR) expression and mutations in the EGFR signaling pathway in correlation with anti-EGFR therapy in head and neck squamous cell carcinomas.
Smilek P; Neuwirthova J; Jarkovsky J; Dusek L; Rottenberg J; Kostrica R; Srovnal J; Hajduch M; Drabek J; Klozar J
Neoplasma; 2012; 59(5):508-15. PubMed ID: 22668015
[TBL] [Abstract][Full Text] [Related]
13. Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells.
Erjala K; Sundvall M; Junttila TT; Zhang N; Savisalo M; Mali P; Kulmala J; Pulkkinen J; Grenman R; Elenius K
Clin Cancer Res; 2006 Jul; 12(13):4103-11. PubMed ID: 16818711
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation-positive non-small cell lung cancers: an update for recent advances in therapeutics.
Chung C
J Oncol Pharm Pract; 2016 Jun; 22(3):461-76. PubMed ID: 25855240
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.
Temam S; Kawaguchi H; El-Naggar AK; Jelinek J; Tang H; Liu DD; Lang W; Issa JP; Lee JJ; Mao L
J Clin Oncol; 2007 Jun; 25(16):2164-70. PubMed ID: 17538160
[TBL] [Abstract][Full Text] [Related]
16. Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC).
Cohen RB
Cancer Treat Rev; 2014 May; 40(4):567-77. PubMed ID: 24216225
[TBL] [Abstract][Full Text] [Related]
17. EGFR mutations in patients with lung adenocarcinoma in southwest China: are G719S/A and L861Q more likely detected in tumors derived from smokers?
Wang Q; Mou J; Yang X; He Y; Li Z; Luo Q; Li Y; Lin L; Ma Y; Xiao H
Lung Cancer (Auckl); 2013; 4():27-33. PubMed ID: 28210132
[TBL] [Abstract][Full Text] [Related]
18. First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.
Sequist LV; Martins RG; Spigel D; Grunberg SM; Spira A; Jänne PA; Joshi VA; McCollum D; Evans TL; Muzikansky A; Kuhlmann GL; Han M; Goldberg JS; Settleman J; Iafrate AJ; Engelman JA; Haber DA; Johnson BE; Lynch TJ
J Clin Oncol; 2008 May; 26(15):2442-9. PubMed ID: 18458038
[TBL] [Abstract][Full Text] [Related]
19. Frequency and significance of epidermal growth factor receptor mutations detected by PCR methods in patients with non-small cell lung cancer.
Nakajima E; Sugita M; Furukawa K; Takahashi H; Uchida O; Kawaguchi Y; Ohira T; Matsubayashi J; Ikeda N; Hirsch FR; Franklin WA
Oncol Lett; 2019 Jun; 17(6):5125-5131. PubMed ID: 31186726
[TBL] [Abstract][Full Text] [Related]
20. Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients.
Chen K; Yu X; Wang H; Huang Z; Xu Y; Gong L; Fan Y
Cancer Chemother Pharmacol; 2017 Dec; 80(6):1179-1187. PubMed ID: 29063948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]